Executive SummaryGCP ClinPlus established a transformative decade-long partnership with a US biotech company, delivering comprehensive biostatistics and SAS programming capabilities that significantly...
In the fast-paced field of oncology drug development, the addition of a new indication often presents complex regulatory, operational, and scientific challenges. In late 2024, ...
GCP ClinPlus Enhances Trial Delivery for a U.S.-Based Ophthalmology SponsorThe ChallengeDuring a critical phase of multiple ophthalmology trials, the sponsor faced fluctuating programming workloads ...
By GCP ClinPlus Biostatistics TeamRare diseases collectively affect 300 million people worldwide, with more than 6,000 distinct disorders identified to date. Most are genetic (72%), predominantly ...
In clinical trials, rework caused by inconsistent data structures, programming errors, or non - compliance with regulatory standards may delay submissions and increase budgets. By adopting proactive ...
